Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000302:isolation & purification* / Q000627:therapeutic use / Q000633:toxicity; D001168:Arthritis / Q000188:drug therapy; D002351:Carrageenan; D003374:Coumarins / Q000302:isolation & purification* / Q000627:therapeutic use / Q000633:toxicity; D003907:Dexamethasone / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005620:Freund's Adjuvant; D006099:Granuloma / Q000188:drug therapy; D007192:Indenes / Q000302:isolation & purification* / Q000627:therapeutic use / Q000633:toxicity; D007213:Indomethacin / Q000627:therapeutic use; D010407:Penicillium / Q000032:analysis*; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats
D000893:Anti-Inflammatory Agents; D003374:Coumarins; D007192:Indenes; D003907:Dexamethasone; D002351:Carrageenan; D005620:Freund's Adjuvant; D010653:Phenylbutazone; D007213:Indomethacin